Invention Grant
- Patent Title: Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
-
Application No.: US17816084Application Date: 2022-07-29
-
Publication No.: US11891607B2Publication Date: 2024-02-06
- Inventor: Jonas Bovijn , Olukayode Sosina , Sirui Zhou , Luca Andrea Lotta , Aris Baras , John Brent Richards
- Applicant: Regeneron Pharmaceuticals, Inc. , The Royal Institution for the Advancement of Learning / McGill University
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.,The Royal Institution For the Advancement of Learning/McGill University
- Current Assignee: Regeneron Pharmaceuticals, Inc.,The Royal Institution For the Advancement of Learning/McGill University
- Current Assignee Address: US NY Tarrytown; CA Montreal
- Agency: Armstrong Teasdale LLP
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C07K16/28 ; C12Q1/6883 ; A61K31/4535 ; A61K31/565 ; A61K31/57 ; A61K31/663 ; A61K31/675 ; A61K38/23 ; A61K38/29
Abstract:
The present disclosure provides methods of treating a subject having decreased bone mineral density or at risk of developing decreased bone mineral density, and methods of identifying subjects having an increased risk of developing decreased bone mineral density.
Public/Granted literature
Information query
IPC分类:
